UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Isotretinoin Sandoz 20 mg Kapsel, mjuk
- Invented name part: Isotretinoin Sandoz
- Strength part: 20 mg
- Pharmaceutical dose form part: Kapsel, mjuk
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Capsule, soft
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 58874
Region: Kingdom of Sweden
Marketing authorisation holder: Sandoz A/S
Identifier:
Status: Valid (2020-06-04)
Package 1 of 1
PCID:
Description: Blister, 100 kapslar
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 10 Blister (PolyVinyl Chloride) (PolyVinylidene Chloride) (Aluminium)
Containing: 10 Capsule
Manufactured Item
Dose form: Capsule, soft
Unit of presentation: Capsule
Ingredient
Role: Active
Substance: Isotretinoin
Concentration strength: 20 milligram(s) / 1 unit(s)
Reference strength: Isotretinoin 20 milligram(s) / 1 unit(s)